# A Phase 1 Drug-drug Interaction Study in Healthy Volunteers

> **NCT02227173** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 20 (actual)

## Conditions studied

- Drug-drug Interaction Study

## Interventions

- **DRUG:** BMS-986020
- **DRUG:** Montelukast
- **DRUG:** Flurbiprofen
- **DRUG:** Digoxin

## Key facts

- **NCT ID:** NCT02227173
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2014-11
- **Final completion:** 2014-11
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2014-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02227173

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02227173, "A Phase 1 Drug-drug Interaction Study in Healthy Volunteers". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02227173. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*